Cargando…

Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression

Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV(1)%...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrocheilou, Argyri, Papagrigoriou-Theodoridou, Maria, Michos, Athanasios, Doudounakis, Stavros-Eleftherios, Loukou, Ioanna, Kaditis, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682578/
https://www.ncbi.nlm.nih.gov/pubmed/29164174
http://dx.doi.org/10.1177/2333794X17738465
_version_ 1783278122966188032
author Petrocheilou, Argyri
Papagrigoriou-Theodoridou, Maria
Michos, Athanasios
Doudounakis, Stavros-Eleftherios
Loukou, Ioanna
Kaditis, Athanasios
author_facet Petrocheilou, Argyri
Papagrigoriou-Theodoridou, Maria
Michos, Athanasios
Doudounakis, Stavros-Eleftherios
Loukou, Ioanna
Kaditis, Athanasios
author_sort Petrocheilou, Argyri
collection PubMed
description Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV(1)%) predicted at age 6 to 7 years were secondary outcomes. Pseudomonas aeruginosa infection prior to 12 months of age was the main explanatory variable. There was no association between early P aeruginosa infection and abnormal CT after adjustment for CFTR (cystic fibrosis transmembrane conductance regulator) functional mutation class, gender, and other pathogens (odds ratio = 0.30; 95% confidence interval = 0.07-1.35; P = .11). No significant associations were demonstrated for BMI z score and FEV(1)% predicted. Children with class I-III CFTR mutations had increased risk of abnormal CT findings (odds ratio = 11.67; 95% confidence interval = 1.11-115.06; P = .035) and lower FEV(1)% predicted (P = .04). In the current era, early-life P aeruginosa infection in CF might not influence the severity of lung disease in school age as much as previously. Larger studies are needed to confirm this finding.
format Online
Article
Text
id pubmed-5682578
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-56825782017-11-21 Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression Petrocheilou, Argyri Papagrigoriou-Theodoridou, Maria Michos, Athanasios Doudounakis, Stavros-Eleftherios Loukou, Ioanna Kaditis, Athanasios Glob Pediatr Health Original Article Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV(1)%) predicted at age 6 to 7 years were secondary outcomes. Pseudomonas aeruginosa infection prior to 12 months of age was the main explanatory variable. There was no association between early P aeruginosa infection and abnormal CT after adjustment for CFTR (cystic fibrosis transmembrane conductance regulator) functional mutation class, gender, and other pathogens (odds ratio = 0.30; 95% confidence interval = 0.07-1.35; P = .11). No significant associations were demonstrated for BMI z score and FEV(1)% predicted. Children with class I-III CFTR mutations had increased risk of abnormal CT findings (odds ratio = 11.67; 95% confidence interval = 1.11-115.06; P = .035) and lower FEV(1)% predicted (P = .04). In the current era, early-life P aeruginosa infection in CF might not influence the severity of lung disease in school age as much as previously. Larger studies are needed to confirm this finding. SAGE Publications 2017-11-08 /pmc/articles/PMC5682578/ /pubmed/29164174 http://dx.doi.org/10.1177/2333794X17738465 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Petrocheilou, Argyri
Papagrigoriou-Theodoridou, Maria
Michos, Athanasios
Doudounakis, Stavros-Eleftherios
Loukou, Ioanna
Kaditis, Athanasios
Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
title Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
title_full Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
title_fullStr Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
title_full_unstemmed Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
title_short Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
title_sort early-life pseudomonas aeruginosa infection in cystic fibrosis and lung disease progression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682578/
https://www.ncbi.nlm.nih.gov/pubmed/29164174
http://dx.doi.org/10.1177/2333794X17738465
work_keys_str_mv AT petrocheilouargyri earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression
AT papagrigorioutheodoridoumaria earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression
AT michosathanasios earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression
AT doudounakisstavroseleftherios earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression
AT loukouioanna earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression
AT kaditisathanasios earlylifepseudomonasaeruginosainfectionincysticfibrosisandlungdiseaseprogression